Methods and formulations for modulating the human sexual respons

Details Methods and formulations for modulating the human sexual respons Methods and formulations for modulating the human sexual respons

1999-07-28

2000-12-26

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31415

Patent

active

061660612

ABSTRACT:
The invention is directed to oral formulations of the vasodilator phentolamine to modulate sexual response on demand.

REFERENCES:
patent: 2503059 (1950-04-01), Miescher et al.
patent: 3937834 (1976-02-01), Hunger et al.
patent: 3943246 (1976-03-01), Sturmer
patent: 4127118 (1978-11-01), Latorre
patent: 4139617 (1979-02-01), Grunwell et al.
patent: 4530920 (1985-07-01), Nestor et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4863911 (1989-09-01), Anderson, Jr. et al.
patent: 4885173 (1989-12-01), Stanley et al.
patent: 5059603 (1991-10-01), Rubin
patent: 5065744 (1991-11-01), Zusmanovsky
patent: 5079018 (1992-01-01), Ecanow
patent: 5145852 (1992-09-01), Virag
patent: 5236904 (1993-08-01), Gerstenberg et al.
patent: 5256652 (1993-10-01), El-Rashidy
patent: 5270323 (1993-12-01), Milne, Jr. et al.
patent: 5298261 (1994-03-01), Pebley et al.
patent: 5399581 (1995-03-01), Laragh et al.
patent: 5565466 (1996-10-01), Gioco et al.
patent: 5731339 (1998-03-01), Lowrey
ABPI Data Sheet Compendium, pp. 186-187 (1976).
ABPI Data Sheet Compendium, pp. 186-189 (1977).
AC-Di-Sol.RTM., Croscarmellose Sodium, NF (Accelerates DisSolution) (Product Description Brochure); FMC Corporation, Philadelphia, PA, pp. 1-9 (1988).
Althof et al., "Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: a long-term prospective study," J. Sex. & Marital Ther., 17(2):101-112 (1991).
Azadzoi, K.M. et al., "Effects of Intracavernosal Trazadone Hydrochloride: Animal and Human Studies," J. Urology, 144(5):1277-1282 (Nov., 1990).
Barnett et al., "The Action of "Regitine" in Man with Special Reference to Its Adrenergic Blocking Action," Australasian Anals of Medicine, 1:109-119 (1952).
Beavo, J.A. et al., In: Advances in Second Messenger and Phosphoprotein Research, Greengard et al,. (eds.), vol. 22, pp. 1-38 (1988).
Becker, A.J. et al., "Oral Phentolamine as Treatment for Erectile Dysfunction," The Journal of Urology, 159:1214-1216 (1998).
Biotechnology Newswatch, "Nice try, but no Viagra, say experts reviewing new potency pills," pp. 4-5 (Jun., 1998).
Brindley, G.S., "Cavernosal alpha-blockade and human penile erection," J. Physiol., 342:24P (1983).
Brindley, G.S., "Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile Impotence," Brit. J. Psychiat., 143:332-337 (1983).
Brindley, G.S., "Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis," Br. J. Pharmac., 87:495-500 (1986).
British Pharmaceutical Codex 1954, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1, pp. 572-575.
British Pharmaceutical Codex 1959, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1, pp. 562-565.
British Pharmaceutical Codex 1968, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1, pp. xxiv-xxvii and 616-619.
British Pharmaceutical Codex 1973, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1A 2NN, pp. 373-374.
British Pharmacopceia 1980, vol. I, London Her Majesty's Stationary Office 1980, p. 344.
British Pharmacop.oe butted.ia 1963, The Pharmaceutical Press 17 Bloomsbury Square London WC1, pp. 600-603.
British Pharmacop.oe butted.ia 1968, The Pharmaceutical Press 17 Bloomsbury Square London WC1, pp. 758-761.
British Pharmacop.oe butted.ia 1973, London Her Majesty's Stationary Office 1973, p. 364.
British Pharmacop.oe butted.ia 1980, vol. II, London Her Majesty's Stationary Office 1980 (see attached--one page).
British Pharmacop.oe butted.ia 1988, vol. I, London Her Majesty's Stationary Office, pp. 434-435.
British Pharmacop.oe butted.ia 1988, vol. II, London Her Majesty's Stationary Office, p. 835.
Corriere, J.N. Jr. et al., "Development of Fibrotic Penile Lesions Secondary to the Intracorporeal Injection of Vasoactive Agents," J. Urology, 140:615-617 (1988).
Dawson, A. et al., "The Transient Anti-Hypertensive Effect of Phentolamine in Patients Receiving Beta-Blocker Treatment," J. Int. Med. Res., 5:462-464 (1977).
Dhar, S.K. et al., "Clinical management of hypertensive emergencies," Heart Lung, 5(4):571-575 (Jul./Aug., 1976).
Diedrichs, W. et al., "Reduction of Sympathetic Influence on Penile Erection by Phentolamine," Urol. Int., 46:64-66 (1991).
Finkbeiner, A.E. et al., "Uropharmacology XI. Adrenergic-Blocking Agents and Drugs Affecting Catecholamine Binding and Release," Urology, 8(6):693-700 (Jun., 1979).
French Pharmaceutical Compendium, p. 1178 (1969).
French Pharmaceutical Compendium, pp. 1704-1705 (1964).
French Pharmaceutical Compendium, pp. 1802-1803 (1965).
Georgopoulos, A.J. et al., "Treatment of Chronic Heart Failure with Slow Release Phentolamine," Europ. J. Clin. Pharmacol., 13:325-329 (1978).
German Drug Compendium, pp. 1028-1029 (1969).
German Drug Compendium, pp. 1054-1055 (1971).
Gissinger, D. et al., "A Comparative Evaluation of the Properties of Some Tablet Disintegrants," Drug Development and Industrial Pharmacy, 6(5):511-536 (1980).
Godbillion et al., "Determination of the Major Metabolite of Phentolamine in Human Plamsa And Urime By High-Performance Liquid Chromatography," J. Chromatography, 222:461-466 (1981).
Gould, L.A. et al., "Oral Therapy with Phentolamine in Chronic Congestive Heart Failure," Chest, 75(4):487-491 (Apr., 1979).
Gwinup, G., "Oral Phentolamine in Nonspecific Erectile Insufficiency," Ann. Int. Med., 109(2):162-163 (Jul., 1998).
Imhof, P.R. et al., "Human Pharmacology of Orally Administered Phentolamine," In: Phentolamine in Heart Failure and Other Cardiac Disorders, Taylor, S.H., and Gould, L.A., (eds.), Ben Huber, pp. 11-22 (1976).
Johnson, B.F. et al., "A controlled trial of oxprenolol and oral phentolamine in the management of hypertension," In: Hypertension--its nature and treatment.Burley, D.M. et al., (eds.). An international symposium, Malta, 18th-21st Oct. 1974. Horsham England, CIBA Laboratories, pp. 259-268 (1975).
Kersting, F. et al., "Clinical Pharmacology of Prazosin and Phentolamine in Patients with Heart Failure," J. Cardiovascular Pharmacology, 2(Suppl. 3):S373-S383 (1980).
Larsen et al., "Fibrosis of Corpus Cavernosum after Intracavernous Injection of Phentolamine/Papaverine," J. Urology, 137:292-293 (Feb., 1987).
Marriot, H.J.L., "An Alarming Pressor Reaction To Regitine," 46(5):1001-1002 (May, 1957).
McCleane, G.J., "Oral Phentolamine Mesylate in the treatment of Complex Regional Pain Syndrome," The Ulster Medical Journal, 65(1):87-88 (May, 1996).
McDonnell, S.M. et al., "Imipramine-induced Erection, Masturbation, and Ejaculation in Male Horses," Pharmacol. Biochem. Behav. (USA), 27(1):187-191 (May, 1987) (Abstract).
Montorsi, F. et al., "Clinical Reliability of Multi-Drug Intracavernous Vasoactive Pharmacotherapy for Diabetic Impotence," Acta Diabetol., 31:1-5 (1994).
Montorsi, F. et al., "Pharmacological Management of Erectile Dysfunction," Drugs, 50(3):465-479 (1995).
NIH Consensus Conference, "Impotence," NIH Consensus Development Panel on Impotence, Journal American Medical Association, 270(1):83-90 (1993).
Parte I Specialita Medicinali E Referimenti Ad Altri Reparti Secondo Ordine Alfabetica , Italian Drug Compendium (L'Infromatore Farmaceutico) pp. 1, 535, and 753 (1979).
Parte I Specialita Medicinali, Italian Drug Compendium (L'Informatore Farmaceutico), pp. 1 and 551 (1975).
Parte I Specialita Medicinali, Italian Drug Compendium (L'Informatore Farmaceutico), pp. 3 and 486 (1969).
Pfister, et al., "Estimation of the Plasma Concentration and Course of Action of Phentol-amine Based On Its Inhibitory Effect On Adrenaline-Induced Platelet Aggregation," Br. J. Clin. Pharmac., 5:175-180 (1978).
Physician's Desk Reference, 37 Edition, pp. 409 and 864 (1983).
Ruskin, J.N. et al., "Primary Pulmonary Hypertension Treated With Oral Phentolamine," Annals of Internal Medicine, 90:772-774 (1979).
Saeed, M. et al., ".alpha.-Adrenoceptor Blockade by Phentolamine Causes .beta.-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic .alpha.-Blockade," Journal of Cardiovascular Pharmacology, 4:44-52 (1982).
Schreiber, R. et al., "Hemodynamic Improvement following a Single Dose of Oral Phentolamine: Administration in Patien

Affiliated with

Also associated with

Rating

Methods and formulations for modulating the human sexual respons does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and formulations for modulating the human sexual respons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and formulations for modulating the human sexual respons will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-995387